ストックスクリーナーアプリを入手
1.47
2.80%
0.04
アフターアワーズ：
1.48
0.01
+0.68%
前日終値:
$1.43
開ける：
$1.49
24時間の取引高:
461.63K
Relative Volume:
2.96
時価総額：
$34.77M
収益：
-
当期純損益:
$-22.29M
株価収益率:
-1.2458
EPS:
-1.18
ネットキャッシュフロー:
$-17.12M
1週間 パフォーマンス:
-0.68%
1か月 パフォーマンス:
+14.84%
6か月 パフォーマンス:
+38.68%
1年 パフォーマンス:
+17.60%
1日の値動き範囲:
$1.43
$1.58
1週間の範囲:
$1.31
$1.58
52週間の値動き範囲:
$0.8101
$1.76
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
ENLV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.47 | 34.11M | 0 | -22.29M | -17.12M | -1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
638.90 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-02 | 繰り返されました | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd (ENLV) 最新ニュース
Enlivex Therapeutics Ltd. stock trendline breakdownChart Pattern Recognition for Profit Timing - Newser
Is a relief rally coming for Enlivex Therapeutics Ltd. holdersBuy/Sell Zone Confirmation Technical Analysis - Newser
Applying big data sentiment scoring on Enlivex Therapeutics Ltd.Long Term Stock Growth Plan Suggestions - Newser
Will Enlivex Therapeutics Ltd. stock go up soonQuick Profit Setup with Signal Forecast - Newser
Can Enlivex Therapeutics Ltd. rally from current levelsFree Daily Momentum Screener With Alerts - Newser
Enlivex Therapeutics Ltd. stock trend forecastTechnical Safety Zone Pattern Recognition - Newser
Real time scanner hits for Enlivex Therapeutics Ltd. explainedFree Real Time Stock Movement Analysis - Newser
Using Bollinger Bands to evaluate Enlivex Therapeutics Ltd.3-Day Market Movement Forecast Analysis - Newser
Why Enlivex Therapeutics Ltd. stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Up 51.7% in July - Defense World
Is Enlivex Therapeutics Ltd. showing signs of accumulationReal-Time AI Generated Market Forecast - Newser
Key metrics from Enlivex Therapeutics Ltd.’s quarterly dataLong-Term Trend Tracking and Signal Summary - Newser
What candlestick patterns are forming on Enlivex Therapeutics Ltd.Consistent Profit Signals with AI Models - Newser
Risk vs reward if holding onto Enlivex Therapeutics Ltd.Smart Trade Mapping with Entry Details - Newser
Enlivex Therapeutics Ltd. stock momentum explainedBuy Strategy with Smart Exit Timing - Newser
What makes Enlivex Therapeutics Ltd. stock price move sharplyFree AI Powered High Return Stock Calls - Newser
What analysts say about Enlivex Therapeutics Ltd. stockInvest in high-yield stocks with confidence - Jammu Links News
When is Enlivex Therapeutics Ltd. stock expected to show significant growthPhenomenal wealth increase - Jammu Links News
What institutional investors are buying Enlivex Therapeutics Ltd. stockAchieve exceptional returns with expert guidance - Jammu Links News
What are the technical indicators suggesting about Enlivex Therapeutics Ltd.Unlock steady growth with low-risk stocks - Jammu Links News
Enlivex Therapeutics Ltd. Stock Analysis and ForecastCapitalize on fast-moving stock opportunities - Jammu Links News
How many analysts rate Enlivex Therapeutics Ltd. as a “Buy”Maximize your gains with expert trading tips - Jammu Links News
What is Enlivex Therapeutics Ltd. company’s growth strategyStay ahead with daily expert stock picks - Jammu Links News
What are the latest earnings results for Enlivex Therapeutics Ltd.Unlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Enlivex Therapeutics Ltd. stock higher in 2025Achieve rapid growth with smart investments - Jammu Links News
Should you wait for a breakout in Enlivex Therapeutics Ltd.Free Capital Growth With Controlled Risk Picks - Newser
Enlivex Therapeutics Ltd (ENLV) 財務データ
収益
当期純利益
現金流量
EPS
3.70%
1.02%
大文字化:
|
ボリューム (24 時間):